Audrey Payancé a, b, c, ⁎ , Pierre François Ceccaldi d, e, Emmanuelle De Raucourt c, f, Dominique Valla a, b, c, Sophie Hillaire g, Danielle Dutheil c, h, Virginia Hernandez-Gea i, Christophe Bureau c, j, Aurélie Plessier a, b, c
a DHU Unity, Department of Hepatology, Beaujon Hospital, AP–HP, 100, boulevard du Général Leclerc, 92118 Clichy, France
b Reference center of vascular liver diseases, European Reference Network (ERN) “Rare-Liver”, Hambourg Germany
c French Network for Rare Liver Diseases FILFOIE, Saint-Antoine Hospital, AP–HP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France
d Department of obstetrics and gynecology, Beaujon Hospital, AP–HP, 100, boulevard du Général Leclerc, 92118 Clichy, France
e Inserm 3PHM « Pathophysiology & Pharmacotoxicology of the Human Placenta, pre & postnatal Microbiota (3PHM)», Faculty of Pharmacy, University of Paris, Paris, France
f Department of haematology, Beaujon Hospital, AP–HP, 100, boulevard du Général Leclerc, 92118 Clichy, France
g Department of Internal Medicine, Foch Hospital, 40, rue Worth, 92150 Suresnes, France
h Association of patients with vascular liver diseases (AMVF), Department of Hepatology, Beaujon Hospital, 100, boulevard du Général Leclerc, 92118 Clichy, France
i Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd). Health Care Provider of the European Reference Network onRare Liver Disorders (ERN-Liver), Spain
j Department of Gastroenterology and Hepatology, Rangueil Hospital, University Hospital of Toulouse, 1, avenue du Professeur Jean-Poulhès, 31400 Toulouse, France